businesspress24.com - ZYTO Reports Record Second Quarter Results
 

ZYTO Reports Record Second Quarter Results

ID: 1142323

Second Consecutive Quarter of Net Income

(firmenpresse) - LINDON, UT -- (Marketwire) -- 08/14/12 -- -- ZYTO Corp (OTCBB: ZYTC) ().

ZYTO Corp, a Utah-based biotech company specializing in biocommunication applications, today reported net income of $31,270 for the second quarter of 2012, compared to a net loss of $66,238 for the same quarter last year, reflecting an increase of $97,508. Total revenues for the second quarter of 2012 increased 18.9% to $1.4 million from $1.18 million in the same quarter last year.

The Company also reported net income of $96,854 for the six months ended June 30, 2012, compared to a net loss of $397,390 for the same period last year, reflecting an increase of $494,244.

"We are delighted to report another quarter of strong momentum as demonstrated by an increase of $222,609 increase in sales over the same period last year," said . "We are fully focused on enhancing our products and expanding our customer base. We continue to build our solid position in the market and improve our customer focus, thereby achieving a steady improvement in our financial performance."

"We are excited to report an increase in net income of almost $500,000 compared to the six months ended June 30, 2011," said Brian E. Halladay, Chief Financial Officer. "We're continuing to invest in our cutting-edge products and services which will drive our business forward."

About ZYTO Corp

ZYTO Corp was founded by its CEO . The company designs and builds computer biocommunication technology to facilitate decision making about healthcare and wellness options.

For more information and to receive a copy of the Company's Quarterly Report, visit or contact their Headquarters at 801-224-7199.

in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to marketing and sales activities by ZYTO's marketing partners, ZYTO product development launches, future growth and research, and enhanced value for ZYTO's stockholders are forward-looking statements. Such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the Company's products, increased levels of competition, new products and technological changes, dependence upon third-party suppliers, intellectual property rights, and other risks detailed from time to time in the Company's periodic reports filed with the U.S. Securities and Exchange Commission. ZYTO disclaims any obligation or intention to update any forward-looking statement contained in this release.







ZYTO Corp

801-224-7199


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  NCSBN Inducts Its Sixth Group of Fellows of the NCSBN Institute of Regulatory Excellence
For Health Equity, Docs Prescribe Public Health Care
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 14.08.2012 - 12:50 Uhr
Sprache: Deutsch
News-ID 1142323
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

LINDON, UT


Phone:

Kategorie:

Hospitals, Facilities and Providers


Anmerkungen:


Diese Pressemitteilung wurde bisher 206 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"ZYTO Reports Record Second Quarter Results
"
steht unter der journalistisch-redaktionellen Verantwortung von

ZYTO Corp (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von ZYTO Corp



 

Who is online

All members: 10 565
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 83


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.